Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, revenue was BRL 2,108.79 million compared to BRL 1,887.83 million a year ago. Net income was BRL 40.25 million compared to BRL 43.97 million a year ago. Basic earnings per share from continuing operations was BRL 0.27 compared to BRL 0.3 a year ago. Diluted earnings per share from continuing operations was BRL 0.27 compared to BRL 0.3 a year ago.